Cargando…
Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients
PURPOSE: Patients with idiopathic pulmonary fibrosis (IPF) show increased PET signal at sites of morphological abnormality on high-resolution computed tomography (HRCT). The purpose of this investigation was to investigate the PET signal at sites of normal-appearing lung on HRCT in IPF. METHODS: Con...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890564/ https://www.ncbi.nlm.nih.gov/pubmed/23942907 http://dx.doi.org/10.1007/s00259-013-2514-8 |
_version_ | 1782299276084248576 |
---|---|
author | Win, Thida Thomas, Benjamin A. Lambrou, Tryphon Hutton, Brian F. Screaton, Nicholas J. Porter, Joanna C. Maher, Toby M. Endozo, Raymondo Shortman, Robert I. Afaq, Asim Lukey, Pauline Ell, Peter J. Groves, Ashley M. |
author_facet | Win, Thida Thomas, Benjamin A. Lambrou, Tryphon Hutton, Brian F. Screaton, Nicholas J. Porter, Joanna C. Maher, Toby M. Endozo, Raymondo Shortman, Robert I. Afaq, Asim Lukey, Pauline Ell, Peter J. Groves, Ashley M. |
author_sort | Win, Thida |
collection | PubMed |
description | PURPOSE: Patients with idiopathic pulmonary fibrosis (IPF) show increased PET signal at sites of morphological abnormality on high-resolution computed tomography (HRCT). The purpose of this investigation was to investigate the PET signal at sites of normal-appearing lung on HRCT in IPF. METHODS: Consecutive IPF patients (22 men, 3 women) were prospectively recruited. The patients underwent (18)F-FDG PET/HRCT. The pulmonary imaging findings in the IPF patients were compared to the findings in a control population. Pulmonary uptake of (18)F-FDG (mean SUV) was quantified at sites of morphologically normal parenchyma on HRCT. SUVs were also corrected for tissue fraction (TF). The mean SUV in IPF patients was compared with that in 25 controls (patients with lymphoma in remission or suspected paraneoplastic syndrome with normal PET/CT appearances). RESULTS: The pulmonary SUV (mean ± SD) uncorrected for TF in the controls was 0.48 ± 0.14 and 0.78 ± 0.24 taken from normal lung regions in IPF patients (p < 0.001). The TF-corrected mean SUV in the controls was 2.24 ± 0.29 and 3.24 ± 0.84 in IPF patients (p < 0.001). CONCLUSION: IPF patients have increased pulmonary uptake of (18)F-FDG on PET in areas of lung with a normal morphological appearance on HRCT. This may have implications for determining disease mechanisms and treatment monitoring. |
format | Online Article Text |
id | pubmed-3890564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-38905642014-01-28 Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients Win, Thida Thomas, Benjamin A. Lambrou, Tryphon Hutton, Brian F. Screaton, Nicholas J. Porter, Joanna C. Maher, Toby M. Endozo, Raymondo Shortman, Robert I. Afaq, Asim Lukey, Pauline Ell, Peter J. Groves, Ashley M. Eur J Nucl Med Mol Imaging Original Article PURPOSE: Patients with idiopathic pulmonary fibrosis (IPF) show increased PET signal at sites of morphological abnormality on high-resolution computed tomography (HRCT). The purpose of this investigation was to investigate the PET signal at sites of normal-appearing lung on HRCT in IPF. METHODS: Consecutive IPF patients (22 men, 3 women) were prospectively recruited. The patients underwent (18)F-FDG PET/HRCT. The pulmonary imaging findings in the IPF patients were compared to the findings in a control population. Pulmonary uptake of (18)F-FDG (mean SUV) was quantified at sites of morphologically normal parenchyma on HRCT. SUVs were also corrected for tissue fraction (TF). The mean SUV in IPF patients was compared with that in 25 controls (patients with lymphoma in remission or suspected paraneoplastic syndrome with normal PET/CT appearances). RESULTS: The pulmonary SUV (mean ± SD) uncorrected for TF in the controls was 0.48 ± 0.14 and 0.78 ± 0.24 taken from normal lung regions in IPF patients (p < 0.001). The TF-corrected mean SUV in the controls was 2.24 ± 0.29 and 3.24 ± 0.84 in IPF patients (p < 0.001). CONCLUSION: IPF patients have increased pulmonary uptake of (18)F-FDG on PET in areas of lung with a normal morphological appearance on HRCT. This may have implications for determining disease mechanisms and treatment monitoring. Springer Berlin Heidelberg 2013-08-14 2014 /pmc/articles/PMC3890564/ /pubmed/23942907 http://dx.doi.org/10.1007/s00259-013-2514-8 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Article Win, Thida Thomas, Benjamin A. Lambrou, Tryphon Hutton, Brian F. Screaton, Nicholas J. Porter, Joanna C. Maher, Toby M. Endozo, Raymondo Shortman, Robert I. Afaq, Asim Lukey, Pauline Ell, Peter J. Groves, Ashley M. Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients |
title | Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients |
title_full | Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients |
title_fullStr | Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients |
title_full_unstemmed | Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients |
title_short | Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients |
title_sort | areas of normal pulmonary parenchyma on hrct exhibit increased fdg pet signal in ipf patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890564/ https://www.ncbi.nlm.nih.gov/pubmed/23942907 http://dx.doi.org/10.1007/s00259-013-2514-8 |
work_keys_str_mv | AT winthida areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients AT thomasbenjamina areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients AT lambroutryphon areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients AT huttonbrianf areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients AT screatonnicholasj areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients AT porterjoannac areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients AT mahertobym areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients AT endozoraymondo areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients AT shortmanroberti areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients AT afaqasim areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients AT lukeypauline areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients AT ellpeterj areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients AT grovesashleym areasofnormalpulmonaryparenchymaonhrctexhibitincreasedfdgpetsignalinipfpatients |